Circa Group Pty Ltd
Bio21 Molecular Science
& Biotechnology Institute
30 Flemington Road, Parkville
VIC 3052 Australia
Twitter @circagroup

Tony Duncan
Chief Executive Officer

Fabien Deswarte
Business Development Manager

c/o Bio 21, Flemington Road

+61 419 303 117

Circa Group is converting waste biomass into advanced biochemical materials.


Circa CEO named Most Innovative Bioeconomy CEO of 2017

Simm Design

Screen Shot 2018-02-28 at 9.18.09 AM edit2 blur.jpg

MELBOURNE, AUSTRALIA and YORK, UK - 7 December 2017. Tony Duncan, Circa CEO, has been voted the Most Innovative Bioeconomy CEO of 2017 by an international audience of bioeconomy experts.

Only the third recipient of the award, Tony is the second Australian winner – a coup for the world’s smallest continent, quietly proving its prowess in bioeconomy innovation.  

“Agriculture and Forestry have always been key industries in Australia, requiring ongoing innovation to compete on global markets. Promisingly for the bioeconomy, there is also strong support here for more sustainable industries,” explains Tony. “I am surprised and delighted to have been awarded this global accolade, and feel it is a true validation of Circa’s approach and team effort over the last nine years.”

Circa defines innovation to include both invention and commercialisation – key tenets in their success to date. In 2017 alone, the team established their 50 Tonne per year prototype in joint venture with Norske Skog and sealed a distribution agreement with Will & Co in key markets, while winning Bio-based Chemical Innovation of the Year for Cyrene in partnership with University of York and distributor Merck Sigma; and making it to the top three bio-based chemicals in the UK with Levoglucosenone.

2018 promises to be full of opportunities, with the commissioning of the prototype manufacturing plant, expected completion of their REACH VIII annex for Cyrene and a further string of exciting joint ventures.

“Importantly, this is our success, not just mine. To get here, it has taken dedicated staff, shareholders, stakeholders and partners. This joint approach is key to bioeconomy innovations: a new interdependence between organisations, built on mutual respect, high trust and an ability to look and work beyond next quarter’s results.”